West Pharmaceutical Services, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | $379.1M | $579.1M | $83.1M |
| FY2010 | $358.1M | $625.7M | $110.2M |
| FY2011 | $299.3M | $654.9M | $161.9M |
| FY2012 | $378.8M | $728.9M | $161.9M |
| FY2013 | $371.3M | $906.4M | $230.0M |
| FY2014 | $308.3M | $956.9M | $255.3M |
| FY2015 | $228.9M | $1.02B | $274.6M |
| FY2016 | $226.2M | $1.12B | $203.0M |
| FY2017 | $197.0M | $1.28B | $235.9M |
| FY2018 | $196.0M | $1.40B | $337.4M |
| FY2019 | $255.0M | $1.57B | $439.1M |
| FY2020 | $252.9M | $1.85B | $615.5M |
| FY2021 | $208.8M | $2.34B | $762.6M |
| FY2022 | $206.7M | $2.68B | $894.3M |
| FY2023 | $72.8M | $2.88B | $853.9M |
| FY2024 | $202.6M | $2.68B | $484.6M |
| FY2025 | $202.8M | $3.18B | $791.3M |